Literature DB >> 20832386

Programme for ultrasound diagnoses and treatment with albendazole of cystic echinococcosis in asymptomatic carriers: 10 years of follow-up of cases.

Edmundo Larrieu1, Mario Del Carpio, Carlos Hugo Mercapide, Juan Carlos Salvitti, Jose Sustercic, Jorge Moguilensky, Héctor Panomarenko, Leonardo Uchiumi, Eduardo Herrero, Gabriel Talmon, Marcela Volpe, Daniel Araya, Gabriel Mujica, Sergio Mancini, José Luis Labanchi, Martín Odriozola.   

Abstract

UNLABELLED: Cystic echinococcosis is an endemic disease in the Province of Rio Negro, Argentina. Ultrasound surveys carried out in 1984 found prevalence rates of 5.6% in children between 6 and 14 years of age.
OBJECTIVE: To describe and to evaluate the results of the strategy applied in school children by hospital services of the Province of Rio Negro with regard to diagnosis, treatment and monitoring of cystic echinococcosis and to evaluate simultaneously the results of the control program against cystic echinococcosis.
MATERIALS AND METHODS: In 1997 ultrasound was chosen to carry out population surveys and the medical treatment criteria for the detected cases were standardized. The population under study involved 5745 students in the first survey and 22,793 in subsequent studies. The detected cases were classified according to Gharbi's scheme. A treatment algorithm was defined based only on monitoring ("watch and wait"), albendazole, surgery (open or laparoscopic) or mini-invasive procedures, according to type, location and size of the cyst. Information was also obtained on cases notified to the Health System between 1980 and 2008.
RESULTS: In the first survey, 70 carriers (1.2%) were detected; of these, 25 started albendazole treatment (35.7%) and only 3 (4.3%) underwent surgery. Ten years after treatment, 60.1% of 42 cases, presented Types IV and V cysts and 14.5% presented total involution of their cysts. In subsequent studies, 87 (0.4%) cases were detected, 49 of which started albendazole treatment (56.3%) and 9 underwent surgery (10.3%). The incidence rate of cystic echinococcosis cases decreased from 38×100,000 in 1980 to 3.7×100,000 in 2008. DISCUSSION: A strong decrease in cystic echinococcosis was obtained although persistent levels of transmission were maintained. The cases produced under these conditions are diagnosed by means of ultrasound surveys and are treated using a plan based on albendazole and monitoring by the Health System during a period of 10 years.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20832386     DOI: 10.1016/j.actatropica.2010.08.006

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  9 in total

1.  Expert Reliability for the World Health Organization Standardized Ultrasound Classification of Cystic Echinococcosis.

Authors:  Nadia Solomon; Paul J Fields; Francesca Tamarozzi; Enrico Brunetti; Calum N L Macpherson
Journal:  Am J Trop Med Hyg       Date:  2017-04-06       Impact factor: 2.345

2.  The Economic Impact of Cystic Echinococcosis in Rio Negro Province, Argentina.

Authors:  Glenda M Bingham; Edmundo Larrieu; Leonardo Uchiumi; Carlos Mercapide; Guillermo Mujica; Mario Del Carpio; Eduardo Hererro; Juan Carlos Salvitti; Bo Norby; Christine M Budke
Journal:  Am J Trop Med Hyg       Date:  2016-01-19       Impact factor: 2.345

3.  Cystic Echinococcosis in Turkana, Kenya: The Role of Cross-Sectional Screening Surveys in Assessing the Prevalence of Human Infection.

Authors:  Nadia Solomon; Eberhard Zeyhle; Jane Carter; John Wachira; Asrat Mengiste; Thomas Romig; Paul J Fields; Calum N L Macpherson
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

4.  Watch and Wait Approach for Inactive Echinococcal Cyst of the Liver: An Update.

Authors:  Raffaella Lissandrin; Francesca Tamarozzi; Mara Mariconti; Tommaso Manciulli; Enrico Brunetti; Ambra Vola
Journal:  Am J Trop Med Hyg       Date:  2018-05-31       Impact factor: 2.345

5.  Early diagnosis, treatment and follow-up of cystic echinococcosis in remote rural areas in Patagonia: impact of ultrasound training of non-specialists.

Authors:  Mario Del Carpio; Carlos Hugo Mercapide; Juan Carlos Salvitti; Leonardo Uchiumi; José Sustercic; Hector Panomarenko; Jorge Moguilensky; Eduardo Herrero; Gabriel Talmon; Marcela Volpe; Daniel Araya; Guillermo Mujica; Arnoldo Calabro; Sergio Mancini; Carlos Chiosso; Jose Luis Labanchi; Ricardo Saad; Sam Goblirsch; Enrico Brunetti; Edmundo Larrieu
Journal:  PLoS Negl Trop Dis       Date:  2012-01-10

6.  Pilot Field Trial of the EG95 Vaccine Against Ovine Cystic Echinococcosis in Rio Negro, Argentina: Second Study of Impact.

Authors:  Edmundo Larrieu; Guillermo Mujica; Charles G Gauci; Katherina Vizcaychipi; Marcos Seleiman; Eduardo Herrero; José Luis Labanchi; Daniel Araya; Luis Sepúlveda; Claudia Grizmado; Arnoldo Calabro; Gabriel Talmon; Thelma Verónica Poggio; Pablo Crowley; Graciela Cespedes; Graciela Santillán; Mariela García Cachau; Roberto Lamberti; Lilia Gino; Meritxell Donadeu; Marshall W Lightowlers
Journal:  PLoS Negl Trop Dis       Date:  2015-10-30

7.  Surveillance of Human Echinococcosis in Castilla-Leon (Spain) between 2000-2012.

Authors:  Amparo Lopez-Bernus; Moncef Belhassen-García; Montserrat Alonso-Sardón; Adela Carpio-Perez; Virginia Velasco-Tirado; Ángela Romero-Alegria; Antonio Muro; Miguel Cordero-Sánchez; Javier Pardo-Lledias
Journal:  PLoS Negl Trop Dis       Date:  2015-10-20

Review 8.  Echinococcus metacestode: in search of viability markers.

Authors:  Bruno Gottstein; Junhua Wang; Oleg Blagosklonov; Frédéric Grenouillet; Laurence Millon; Dominique A Vuitton; Norbert Müller
Journal:  Parasite       Date:  2014-11-28       Impact factor: 3.000

9.  Abdominal Cystic Echinococcosis Treated with Albendazole. A Pediatric Cohort Study.

Authors:  Samanta Moroni; Guillermo Moscatelli; Facundo García Bournissen; Nicolás González; Griselda Ballering; Héctor Freilij; Fabián Salgueiro; Jaime Altcheh
Journal:  PLoS One       Date:  2016-09-02       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.